6-methyluracil has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kharlamova, AD; Kots, ED; Krejci, E; Lushchekina, SV; Masson, P; Nachon, F; Nikolsky, EE; Petrov, KA; Reznik, VS; Villard-Wandhammer, M; Zobov, VV; Zueva, IV | 1 |
1 other study(ies) available for 6-methyluracil and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment.
Topics: Acetylcholinesterase; Animals; CHO Cells; Cholinesterase Inhibitors; Cricetinae; Cricetulus; Humans; Mice; Molecular Docking Simulation; Myasthenia Gravis; Quaternary Ammonium Compounds; Uracil | 2016 |